PROKIDNEY CORP.·4

Jul 13, 4:17 PM ET

Fox Jennifer A. 4

4 · PROKIDNEY CORP. · Filed Jul 13, 2023

Insider Transaction Report

Form 4
Period: 2023-07-12
Transactions
  • Award

    Director stock option (right to buy)

    2023-07-12+46,63246,632 total
    Exercise: $10.92Exp: 2033-07-12Class A Ordinary Shares (46,632 underlying)
  • Award

    Director stock option (right to buy)

    2023-07-12+42,51542,515 total
    Exercise: $10.92Exp: 2033-07-12Class A Ordinary Shares (42,515 underlying)
Footnotes (2)
  • [F1]The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting subject to Ms. Fox's continued service with the Company through the applicable vesting date.
  • [F2]The option shall vest and become exercisable in two equal annual installments on July 11, 2024 and July 11, 2025 subject to Ms. Fox's continued service with the Company through the applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION